On September 12 2014, RIVM organised the symposium ‘Acceptation of and communication about the National Immunisation Programme’.

Two Dutch doctors working for an NGO (the Lion Heart Foundation) will be evacuated from Sierra Leone.

Every four years, RIVM assesses the quality, accessibility and affordability of the Dutch healthcare system.

RIVM has created an overview of the possible risks of Bisphenol A (BPA) for humans and the environment. BPA is a component of many different products and affects the endocrine system.

RIVM has sent a message to Community Health Services (GGD's) containing information about how issues concerning Ebola are arranged in the Netherlands.

In recent years the Netherlands has witnessed an increase in the number of cases of gastroenteritis caused by the Campylobacter bacterium.

In our annual report, we look back at compelling RIVM projects and research in 2013.

August 8th the World Health Organization declared the Ebola outbreak in West Africa an international health emergency and appealed for global aid to help afflicted countries.

RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).

Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.